Mechano-redox control of integrin de-adhesion

Freda Passam, Joyce Chiu, Lining Arnold Ju, Aster E. Pijning, Zeenat Jahan, Ronit Mor-Cohen, Adva Yeheskel, Katra Kolšek, Lena Thärichen, Camilo Aponte‐Santamaría, Frauke Gräter, Philip J. HoggeLife 2018 · DOI

TL;DR

This paper reveals a fascinating mechanism where mechanical force and ligand binding work together to trigger a chemical reaction within the integrin αIIbβ3 receptor, leading to its detachment from fibrinogen. This "mechano-redox" control is mediated by the enzyme ERp5, which cleaves a specific disulfide bond in the integrin, offering new insights into how cells regulate adhesion and potentially impacting strategies for controlling blood clotting.

What Problem Does This Paper Address?

Cell surface receptors, like integrins, are crucial for cell-cell and cell-extracellular matrix interactions. While much is known about how these receptors become activated and bind to their ligands (e.g., fibrinogen for platelet integrin αIIbβ3, essential for blood clotting), the mechanisms by which they release these ligands and become inactive have been less understood. This paper specifically investigates how the platelet integrin αIIbβ3 disengages from fibrinogen, a critical step in regulating clot formation and preventing excessive clotting. The challenge lies in understanding the interplay of chemical signals and physical forces that govern this de-adhesion process.

Methods

The researchers employed a multi-pronged approach:

  • Biochemical Assays: They used immunoblotting to detect ERp5 in platelet lysates and releasates, and measured ERp5 binding to β3 integrin.
  • Platelet Adhesion Assays: They used flow chambers to observe how washed platelets adhered to fibrinogen under varying shear stress conditions, both with and without ERp5.
  • Force Spectroscopy (Biomembrane Force Probe - BFP): This technique allowed them to directly measure the forces involved in αIIbβ3-fibrinogen bond formation and dissociation, and how ERp5 affected bond lifetimes under controlled forces.
  • Mass Spectrometry (Differential Cysteine Alkylation): This was a key technique to precisely determine the redox state of disulfide bonds within the β3 integrin subunit, identifying which bonds were cleaved by ERp5.
  • Cell Adhesion and Binding Assays: They used engineered BHK cells expressing wild-type or mutant αIIbβ3 integrins to assess fibrinogen binding and cell adhesion.
  • Molecular Dynamics (MD) Simulations: These simulations provided a detailed atomic-level view of how disulfide bond cleavage affected the flexibility and allosteric signaling within the integrin headpiece.
  • Structural Modeling: They modeled the open conformation of the αIIbβ3 integrin ectodomain to understand the spatial relationships of key residues and disulfide bonds.

Datasets

Not discussed in the paper. The study relies on experimental data generated from platelet and cell cultures, and computational simulations.

Key Insights and Ideas

  • Mechano-Redox Coupling: The most striking insight is the direct coupling of mechanical force and a redox (chemical reduction) event to control protein function. ERp5 doesn't just cleave a disulfide bond; its efficiency is significantly enhanced by mechanical force.
  • Force-Activated Disulfide Cleavage: Ligand binding primes the integrin for ERp5 action, but it's the application of mechanical force (like shear stress in blood flow) that truly accelerates the cleavage of the Cys177-Cys184 disulfide bond.
  • Allosteric Network Activation: Cleavage of this specific disulfide bond, though located away from the ligand-binding site, triggers long-range allosteric changes within the integrin. This affects metal-binding sites and increases the flexibility of the βI-domain, ultimately leading to fibrinogen release.
  • ERp5 Specificity: The study highlights that ERp5, unlike its relative PDI, specifically targets the Cys177-Cys184 disulfide bond in the βI-domain of αIIbβ3, and this specificity requires both catalytic domains of ERp5.
  • Implications for Thrombus Regulation: This mechanism provides a way for platelets to actively disengage from fibrinogen, potentially limiting excessive clot growth and offering a new target for anti-thrombotic therapies.

Key Results

  • ERp5 does not activate αIIbβ3 integrin but mediates the release of fibrinogen from activated integrins.
  • Fluid shear stress significantly enhances ERp5's ability to cause fibrinogen de-adhesion from αIIbβ3.
  • Force spectroscopy revealed that ERp5 dramatically reduces the lifetime of αIIbβ3-fibrinogen bonds at forces above 15 pN.
  • Mass spectrometry identified the Cys177-Cys184 disulfide bond in the βI-domain of αIIbβ3 as the specific target cleaved by ERp5.
  • Cleavage of the Cys177-Cys184 disulfide bond in engineered cells significantly impaired fibrinogen binding and cell adhesion.
  • MD simulations showed that disulfide reduction increases the flexibility of the integrin headpiece and propagates stress to the metal-binding sites.

Limitations and Future Work

  • In Vivo Complexity: While the study provides strong mechanistic insights, the authors acknowledge that ERp5 likely has multiple substrates in the complex environment of a thrombus. Further in vivo studies are needed to fully understand its role in thrombus formation and propagation.
  • Other Integrins and Oxidoreductases: The Cys177-Cys184 disulfide bond is conserved in many integrins, and other oxidoreductases (like PDI and ERp57) also interact with integrins. The authors suggest that similar mechano-redox regulation might control other integrin-protein interactions.
  • Therapeutic Targeting: The potential for targeting ERp5 or this mechano-redox pathway for anti-thrombotic therapies is highlighted, but careful consideration of potential unintended consequences due to ERp5's broader roles is necessary.
  • Disulfide Bond Reformation: The paper notes that the disulfide bond could reform, implying a potential for re-engagement of fibrinogen, which warrants further investigation.

Summary updated

Abstract

How proteins harness mechanical force to control function is a significant biological question. Here we describe a human cell surface receptor that couples ligand binding and force to trigger a chemical event which controls the adhesive properties of the receptor. Our studies of the secreted platelet oxidoreductase, ERp5, have revealed that it mediates release of fibrinogen from activated platelet αIIbβ3 integrin. Protein chemical studies show that ligand binding to extended αIIbβ3 integrin renders the βI-domain Cys177-Cys184 disulfide bond cleavable by ERp5. Fluid shear and force spectroscopy assays indicate that disulfide cleavage is enhanced by mechanical force. Cell adhesion assays and molecular dynamics simulations demonstrate that cleavage of the disulfide induces long-range allosteric effects within the βI-domain, mainly affecting the metal-binding sites, that results in release of fibrinogen. This coupling of ligand binding, force and redox events to control cell adhesion may be employed to regulate other protein-protein interactions.
BibTeX
@inproceedings{passam2018mechano,
  author = {Freda Passam and Joyce Chiu and Lining Arnold Ju and Aster E. Pijning and Zeenat Jahan and Ronit Mor-Cohen and Adva Yeheskel and Katra Kolšek and Lena Thärichen and Camilo Aponte‐Santamaría and Frauke Gräter and Philip J. Hogg},
  title = {{Mechano-redox control of integrin de-adhesion}},
  booktitle = {eLife},
  year = {2018},
  doi = {10.7554/elife.34843},
}
Figure